CLBT

Cellebrite DI Ltd.

1 day chart

About CLBT

Cellebrite DI Ltd is an Israel-based software developer. The Company is committed to providing a Digital Intelligence (DI) platform for managing DI in legally sanctioned investigations. The Platform enables users to collect, view, analyse and manage digital data throughout the entire investigation cycle. The Company's platform improves the investigation process for public defenders, police departments, state departments, armed services, legal and corporate security; this leads to an accelerated speed of investigations and increased crime clearance rates.

Buy US stocks in Australia starting with CLBT. Open an account and start investing today!

Market Capitalisation

$1.12B

Price-earnings ratio

Dividend yield

0.00%

Volume

High today

$5.83

Low today

$5.49

Open price

$0.00

52-week high

$6.23

52-week low

$3.80

CLBT FAQs

Can I buy CLBT shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?

Yes, the Stake platform allows you to buy CLBT shares and over 8,000 stocks and ETFs across the ASX and Wall St.

How much is one share of Cellebrite DI Ltd.?

One share of Cellebrite DI Ltd. is valued at $5.78.

What is the ticker symbol for Cellebrite DI Ltd.?

The ticker symbol for Cellebrite DI Ltd. is CLBT.

How do I buy CLBT shares in Australia?

To buy CLBT stocks in Australia you'll need to open an account with a broker like Stake.
To do so follow these steps:

Sign up in minutes, all you need is some I.D.
Choose Stake Wall St
Deposit directly into your Stake wallet and you're ready to invest in CLBT

What is the 52-week high for Cellebrite DI Ltd. stock?

The Cellebrite DI Ltd. 52-week high stock price is $6.23.

What is the 52-week low for Cellebrite DI Ltd. stock?

The Cellebrite DI Ltd. 52-week low stock price is $3.80.

What is the market capitalisation of Cellebrite DI Ltd. CLBT?

As of 01/06/2023 Cellebrite DI Ltd. has a market cap of $1.1B.

Related Stocks

This does not constitute financial advice. You should do your own research before making an investment decision. Past performance is not a reliable indication of future performance. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.